MAXACT Trademark
Trademark Overview
On Monday, December 3, 1990, a trademark application was filed for MAXACT with the United States Patent and Trademark Office. The USPTO has given the MAXACT trademark a serial number of 74119805. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, May 5, 1992. This trademark is owned by Burroughs Wellcome Co.. The MAXACT trademark is filed in the Pharmaceutical Products category with the following description:
antihistamine/decongestant
General Information
| Serial Number | 74119805 |
| Word Mark | MAXACT |
| Filing Date | Monday, December 3, 1990 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Tuesday, May 5, 1992 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | antihistamine/decongestant |
| Pseudo Mark | Maximum Act |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 018 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Wednesday, August 4, 1999 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Burroughs Wellcome Co. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Research Triangle Park, NC 27709 |
Trademark Events
| Event Date | Event Description |
| Tuesday, May 5, 1992 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Thursday, June 20, 1991 | NON-FINAL ACTION MAILED |
| Monday, March 18, 1991 | ASSIGNED TO EXAMINER |
